CompanyDrug

RemeGen’s RC118 Receives Orphan Drug Designations for Gastric and Pancreatic Cancers

CompanyDrug

Innovent Biologics Presents Clinical Study Results at ESMO-IO 2022

Policy / Regulatory

NMPA Extends Validation Period for COVID-19 Antigen Detection Reagents

CompanyDeals

Science Standard Medical Testing Raises Pre-Series A Funding

CompanyDeals

Phanes Therapeutics and BeiGene Partner on Phase I Study of PT199

CompanyDeals

XtalPi Partners with CTTQ for AI-Driven Small-Molecule Drug Development

CompanyDrug

Harbour BioMed Concludes Phase I Study for HBM4003 in Advanced Melanoma

CompanyDeals

Frontier Biotechnologies Partners with Yuyue Med for FB2001 Atomizer

CompanyDeals

Harbour BioMed’s Nona Biosciences Licenses Antibody Platform to Kelun-Biotech

CompanyDeals

ExoNeuglia Secures Angel Funding for iPSC-Based Cell Therapy

CompanyDrug

Jacobio’s KRAS G12C Inhibitor JAB-21822 Receives Breakthrough Therapy Designation

CompanyDrug

CSPC and Ascletis Get NMPA Approval for COVID-19 Drug Clinical Trials